UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
15.99 +1.29 (+8.78%) 01/22/25 [NASDAQ]
10.00 x 500 25.58 x 200
Realtime by (Cboe BZX)
10.00 x 500 25.58 x 200
Realtime - - (-) -
News & Headlines for Wed, Jan 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
5 Stocks Retail Investors Are Most Bullish On At Mid-Day

Retailers went overboard about a couple of biotech stocks and a MedTech name, among others on Wednesday.

FBRX : 15.99 (+8.78%)
QSI : 2.38 (-2.46%)
DUOT : 6.80 (+15.25%)
IBB : 136.29 (+0.14%)
SLXN : 0.7417 (-3.68%)
SPY : 606.44 (+0.56%)
XBI : 91.21 (+0.77%)
ZIM : 16.52 (+1.72%)
Forte Biosciences Stock More Than Doubles On Oversubscribed $53M Private Placement: Retail Goes Wild

The funds will support clinical development of FB102, Forte’s proprietary anti-CD122 monoclonal antibody targeting autoimmune and autoimmune-related diseases.

FBRX : 15.99 (+8.78%)
VXF : 200.23 (-0.32%)
VTI : 300.60 (+0.49%)
ONEQ : 78.80 (+1.18%)
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy

The Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product...

MMED.NE : 14.9000 (+9.48%)
MNMD : 7.01 (-2.44%)
INCY : 72.41 (-1.44%)
SGEN : 228.74 (-0.07%)
PFE : 26.01 (-2.36%)
FBRX : 15.99 (+8.78%)
JAZZ : 120.84 (-0.49%)
ALC : 88.78 (+0.27%)
MindMed Files Preliminary Proxy Statement for 2023 Annual Meeting

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...

MMED.NE : 14.9000 (+9.48%)
MNMD : 7.01 (-2.44%)
INCY : 72.41 (-1.44%)
BMY : 57.09 (+0.09%)
SGEN : 228.74 (-0.07%)
FBRX : 15.99 (+8.78%)
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced full year 2022 results and provided a business update.

FBRX : 15.99 (+8.78%)
Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Mr. David Gryska has been appointed to the Forte Biosciences Board of Directors.

FBRX : 15.99 (+8.78%)
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), announced today that Dr. Scott Brun, M.D. has been appointed to the Forte Biosciences Board of Directors.

FBRX : 15.99 (+8.78%)
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced third quarter 2022 results and provided a business update.

FBRX : 15.99 (+8.78%)
Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise

Camac Partners, LLC (together with its affiliates, "Camac" or “we”), which is one of the largest shareholders of Forte Biosciences, Inc. (Nasdaq: FBRX) (“Forte” or the “Company”), today expressed...

FBRX : 15.99 (+8.78%)
Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced second quarter 2022 results and provided a business update.

FBRX : 15.99 (+8.78%)

Barchart Exclusives

BofA Predicts No Rate Cuts in 2025: 3 Dividend Stocks to Watch
With Bank of America predicting no Federal Reserve rate cuts in 2025, investors may turn to high-dividend stocks for stable income and potential growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar